Latest Lead News

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.

Paladin Energy has launched a fully underwritten A$300 million equity raising to advance its Patterson Lake South uranium project, aiming for a Final Investment Decision and first production by 2031.

Lincoln Minerals has expanded its exploration footprint at the Minbrie Copper-Base Metals Project, identifying two new drill-ready targets and confirming a large-scale multi-metal sulphide system stretching over 7km. Fully funded for drilling, the company aims to unlock significant growth potential in South Australia’s Eyre Peninsula.

Variscan Mines has acquired extensive historic drilling data over newly granted licences in northern Spain, revealing significant high-grade zinc and lead mineralisation and unlocking a district-scale exploration opportunity.

Oceania Healthcare has unveiled a comprehensive strategy focused on sales performance, operational excellence, and capital management to strengthen its aged care and retirement living portfolio. The company aims to reduce debt, enhance resident choice, and expand services while maintaining strong occupancy and shareholder returns.

Elevra Lithium finalizes merger of Piedmont and Sayona, creating North America’s largest hard-rock lithium producer with a combined resource base of 229Mt. The company outlines ambitious growth plans, operational efficiencies, and a strengthened financial position to capitalize on rising lithium demand.

Sayona Mining’s recent scoping study for its North American Lithium operation reveals a significant expansion, boosting production capacity and reducing costs while delivering robust financial returns.

Thrive Tribe Technologies has raised approximately $500,000 through a discounted share placement, aiming to bolster its working capital. The move follows shareholder approval and involves a significant issuance of new shares.

Downer EDI Limited has announced its key shareholder dates for 2025, including the Annual General Meeting scheduled for November 11 and the final dividend payment on October 2. These dates mark important milestones for investors in one of Australia and New Zealand's leading infrastructure service providers.

Alterity Therapeutics has unveiled encouraging Phase 2 trial results for ATH434, demonstrating its potential to slow disease progression in Multiple System Atrophy while maintaining a strong safety profile.

Flynn Gold has initiated its first-ever diamond drilling program at the historically rich Double Event gold prospect in Northeast Tasmania, following trenching that revealed an extensive mineralised corridor. The drilling aims to validate and expand on promising surface assay results, potentially unlocking significant value for the Golden Ridge Project.

360 Capital Group has received an unconditional $0.30 per security takeover offer from TT Investments, prompting the formation of an Independent Board Committee to evaluate the bid and advise securityholders.